Long-term outcome of low and intermediate risk differentiated thyroid carcinoma patients who had initial R0 dissection and received no radioiodine therapy

Conclusions: If one could achieve initial R0 dissection in low and intermediate risk DTC patients, the requirement of remnant ablation/adjuvant RAI therapy becomes superfluous, in view of very low recurrence rate (overall 3.6%, 2.6% in low and 6.4% in intermediate risk group) with median follow up of 69 months. However, current criteria for risk stratification to call low and intermediate risk DTC needs further refinement.

Source: Journal of Nuclear Medicine - May 14, 2020 Category: Nuclear Medicine Authors: Tupalli, A., Reddy, S., HEMROM, A., Mohan, N., Mangu, B., KUMAR, A., Bal, C. Tags: New Trends in Endocrine Therapy Source Type: research